Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
4.1%
1w
10.1%
1m
18.3%
3m
42.0%
6m
38.4%
1y
2.4%
all
19.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,575 4.1%
1,017
1,598
Company Overview
Sales
1,108 Cr
Growth: -8.7%
Profit after Tax
275 Cr
Growth: 5.5%
Mid Cap
16,477 Cr
P/E: 60.4x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 1,108
Growth -8.7%
EBITDA 35.0%
P/S 14.9x
Dividend 0.6%
P/E 60.4x
Book Value ₹ 198
PEG Ratio -6.9x
ROE 13.8%
P/B 7.8x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (24 Indices) view more
Followers (1)
varsha96